Biomarkers of Inflammatory Bowel Disease

被引：63

作者：

Yi Fengming ^{[1
]}

Wu Jianbing ^{[1
]}

机构：

[1] Nanchang Univ, Affiliated Hosp 2, Dept Oncol, Nanchang 330006, Jiangxi, Peoples R China

来源：

DISEASE MARKERS | 2014年 / 2014卷

关键词：

SACCHAROMYCES-CEREVISIAE ANTIBODIES; ACTIVE ULCERATIVE-COLITIS; FECAL PYRUVATE-KINASE; MEAN PLATELET VOLUME; C-REACTIVE PROTEIN; CROHNS-DISEASE; INTESTINAL INFLAMMATION; NONINVASIVE MARKER; DIAGNOSTIC-VALUE; INDETERMINATE COLITIS;

D O I：

10.1155/2014/710915

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Inflammatory bowel disease (IBD) is a chronic disease mostly involved with intestine with unknown etiology. Diagnosis, evaluation of severity, and prognosis are still present as challenges for physicians. An ideal biomarker with the characters such as simple, easy to perform, noninvasive or microinvasive, cheap, rapid, and reproducible is helpful for patients and clinicians. Currently biomarkers applied in clinic include CRP, ESR, pANCA, ASCA, and fecal calprotectin. However, they are far from ideal. Lots of studies are focused on seeking for ideal biomarker for IBD. Herein, the paper reviewed recent researches on biomarkers of IBD to get advances of biomarkers in inflammatory bowel disease.

引用

页数：11

共 50 条

[21] Assessing seasonal variations of biomarkers in inflammatory bowel disease
Neamti, Lidia
Drugan, Tudor Catalin
Drugan, Cristina
Silaghi, Ciprian
Ciobanu, Lidia
Ilyes, Tamas
Craciun, Alexandra
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2024, 36 (08) : 993 - 999
[22] The Role of Biomarkers in Clinical Trials of Inflammatory Bowel Disease
Khanna, Reena
Narula, Neeraj
Feagan, Brian G.
INFLAMMATORY BOWEL DISEASES, 2018, 24 (08) : 1619 - 1623
[23] Novel new noninvasive biomarkers of inflammatory bowel disease
Kapoor, Shailendra
INFLAMMATORY BOWEL DISEASES, 2008, 14 (09) : 1317 - 1317
[24] Biomarkers of inflammatory bowel disease: ready for prime time?
Plebani, Mario
Basso, Daniela
Lippi, Giuseppe
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2015, 53 (12) : 1881 - 1882
[25] Role of Biomarkers in the Diagnosis and Treatment of Inflammatory Bowel Disease
Wagatsuma, Kohei
Yokoyama, Yoshihiro
Nakase, Hiroshi
LIFE-BASEL, 2021, 11 (12):
[26] Value of mucosal assessment and biomarkers in inflammatory bowel disease
Stidham, Ryan W.
Higgins, Peter D. R.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 4 (03) : 285 - 291
[27] The Current Status of Molecular Biomarkers for Inflammatory Bowel Disease
Alghoul, Zahra
Yang, Chunhua
Merlin, Didier
BIOMEDICINES, 2022, 10 (07)
[28] An update on diagnostic and prognostic biomarkers in inflammatory bowel disease
Day, Andrew S.
Leach, Steven T.
Lemberg, Daniel A.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2017, 17 (09) : 835 - 843
[29] The role of fecal biomarkers in individuals with inflammatory bowel disease
Edwards, Teagan S.
Day, Andrew S.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2024, 24 (06) : 497 - 508
[30] The Utility of Biomarkers in the Diagnosis and Therapy of Inflammatory Bowel Disease
Lewis, James D.
GASTROENTEROLOGY, 2011, 140 (06) : 1817 - U160

← 1 2 3 4 5 →